Case Report: Blinatumomab as upfront consolidation and maintenance therapy in a pediatric patient with high-risk B-cell acute lymphoblastic leukemia

INTRODUCTION: B-cell acute lymphoblastic leukemia (B-ALL) is the most common malignancy in children. The current conventional chemotherapy regimens have high overall survival but with significant short- and long-term toxicities, sometimes requiring delay and termination of chemotherapy. Bispecific T...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Sumit, Casey, Jessica, Lasky, Joseph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10646316/
https://www.ncbi.nlm.nih.gov/pubmed/38023197
http://dx.doi.org/10.3389/fonc.2023.1246924

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10646316/
https://www.ncbi.nlm.nih.gov/pubmed/38023197
http://dx.doi.org/10.3389/fonc.2023.1246924

Ejemplares similares